True North Therapeutics Company Profile, Contacts & Intelligence

True North Therapeutics Overview

True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases of high unmet clinical need. The company’s lead monoclonal antibody, TNT009, targets the Classical Complement pathway, enabling selective inhibition of downstream phagocytosis, inflammation, and cell lysis. True North is currently focused on Complement-mediated rare diseases in the hematologic, renal, and neurological space. True North was formed in 2013 as a spin-out of iPierian.

Headquarters

South San Francisco, California, United States

Website

truenorthrx.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

True North Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Compare Similar Companies to True North Therapeutics

Explore companies in related markets and compare their industry and employee estimates.